drugset / Trial / NCT03570294

Oxidative Stress in Women Treated With Atosiban for Impending Preterm Birth

NCT03570294

NaSingle-groupOpen-labelTreatment

Summary

Oxidative stress is recognized as a important factor in the pathogenesis premature birth. Preterm birth is defined as delivery before 37 completed weeks of gestation and it is the leading cause of neonatal morbidity and mortality. The investigators conducted this analysis to investigate the safety of administration of Atosiban - a reversible, competitive antagonist of the oxytocin receptor in the treatment of preterm labor and its impact on the level of oxidative stress after 48 hours of tocolytic treatment.

Timeline

Start
2014-02-01
Primary completion
2018-06-10
Completion
2018-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Atosiban Other / unclassified 100 ug Intravenous

Indications

No indication recorded.